You’re Receiving This Because You're a Valued Stocks Telegraph Subscriber
This newsletter, The Earnings Edge, is your new go-to for fast, sharp insights on who’s crushing it this earnings season—and who’s flopping. But if this isn’t your thing, no worries. Just click the unsubscribe link at the bottom and you’ll be removed from this new series (you’ll still get your regular updates from us).
Grades are in! Earnings season is like a report card for companies, and today we’re covering who made the honor roll and who’s in need of a retake. With the market reacting to every beat and miss, now is the time to see who’s delivering results that matter. In today’s newsletter, we break down the top performers, the biggest flops, and a few surprise names to watch. Stay tuned for today’s pre-hours earnings reports—these early announcements will give you a head start on understanding today’s market trends and making informed decisions.
Major Earnings Before Opening Bell
Here are some key companies releasing earnings before the market opens on Tuesday.
Sea Ltd ADR (SE)
EPS Estimate: $0.91, showing a 225% year-over-year increase.
Revenue Forecast: $4.89B, up compared to last year’s $3.73B.
Earnings Reaction History: Of the past 6 earnings releases, SE rose in 4 of them, with a standout 7.3% jump in November 2023. Post-earnings volatility averaged 2.37%.
JD.com Inc ADR (JD)
EPS Estimate: $7.09, representing a 25.49% increase from last year.
Revenue Forecast: $290.59B vs $260.05B reported a year ago.
Earnings Reaction History: In its last 6 reports, the stock has shown a balanced mix of positive and negative post-earnings sessions. The stock averaged a post-earnings swing of 1.75%.
On Holding AG (ONON)
EPS Estimate: $0.28, down -18.07% compared to last year.
Revenue Forecast: $680.5M, up from $508.2M a year earlier.
Earnings Reaction History: In the last 6 reports, ONON stock climbed 5 times, with a notable 8.62% surge in March 2024. On average, earnings swings were around 2.92%.
A medical AI startup seems to be on a classic tech stock path to major-league success. It's run by trailblazers. It's trimmed losses to the bone. It aggressively entered a $95-billion medical market. So, it looks poised for its first profitable year. This should be a green-light moment while their share price is ultra-low.
The Timing May Never Be Better. Here's Where To Find The Whole Story
Sponsored
Upcoming Earnings Reports
Below is a list of notable companies reporting earnings today.
Ticker | EPS | Revenue | ST Score |
|---|---|---|---|
DAC | $6.43 | $242.0M | 68.0 |
GAIN | $0.23 | $25.89M | 61.0 |
IGT | $0.28 | $627.84M | 58.0 |
BKTI | $0.44 | $17.0M | 57.0 |
AMS | $0.04 | $8.63M | 53.0 |
Monday's Top Beats
Here are the top earnings beats from recent reports:
Allot Ltd (ALLT)
EPS: $0.02, beating estimates by 140.0%.
Revenue: $23.15 M, exceeding expectations by 14.6%.
Market Reaction: ALLT shares rose by 24.13% following the earnings report.
CytomX Therapeutics Inc (CTMX)
EPS: $0.27, exceeding expectations by 116.43%.
Revenue: $50.92 M, surpassing estimates by 43.36%.
Market Reaction: CTMX stock price increased by 129.43% after the announcement.
Sally Beauty Holdings Inc (SBH)
EPS: $0.42, reflecting a positive earnings surprise of 7.0%.
Revenue: $883.15 M, missing estimates by -2.07%.
Market Reaction: SBH stock price rose by 22.15% following the report.
Massive compute demand is choking AI's growth. While others wait, this firm is building infrastructure now-with elite GPUs and long-term contracts.
Discover how this AI company is helping power a $356B future
Sponsored
Monday's Top Miss
While some companies exceeded expectations, others fell short. Here’s a look at Monday’s top earnings miss:
Macerich Co (MAC)
EPS: -$0.20, underperforming estimates by -127.26%.
Revenue: $249.22 M, coming in 19.32% below analyst projections.
Market Reaction: MAC shares rise 10.41% following the earnings release.
Surgery Partners Inc (SGRY)
EPS: $0.04, missing analyst estimates by -39.47%.
Revenue: $776 M, slightly under the target by -0.17%.
Market Reaction: Post earnings, SGRY stock rose 4.96%.
ImmunityBio Inc (IBRX)
EPS: -$0.15, missing estimates by -17.19%.
Revenue: $16.52 M, falling short of expectations by 3.44%.
Market Reaction: IBRX stock price rose by 14.01% post earnings release.
The Numbers Don’t Lie!
Missed earnings can be lessons in disguise, while beats can set the stage for bullish momentum. Take this knowledge, apply it to your strategy, and continue to build a portfolio that's ready for whatever the market throws your way. Stay tuned for more updates on the biggest winners and losers of the week!
Till next time,
Stocks Telegraph Team
📢 What do you think of our new 'Earnings Edge' newsletter?
💬 Got suggestions or feedback? We’d love to hear from you! Just hit reply to this email and share your thoughts.
📢 Enjoying this newsletter? Share it with your friends and invite them to subscribe using your referral link – let’s grow smarter together!
🛑 Don’t want to receive this newsletter? Simply click the unsubscribe button below to opt out anytime—no hard feelings!
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.
